APA Citatie

Struve, N., Brend, T., Ott, L., Petersen, C., Rothkamm, K., Short, S. C., & Kriegs, M. (2016). P06.20 EGFRvIII: A predictive marker for Temozolomide response in O6-methylguanine-DNA methyltransferase negative glioblastoma cells and tumor xenografts. Neuro Oncol.

Chicago Style citaat

Struve, N., T. Brend, L. Ott, C. Petersen, K. Rothkamm, S. C. Short, en M. Kriegs. "P06.20 EGFRvIII: A Predictive Marker for Temozolomide Response in O6-methylguanine-DNA Methyltransferase Negative Glioblastoma Cells and Tumor Xenografts." Neuro Oncol 2016.

MLA citatie

Struve, N., et al. "P06.20 EGFRvIII: A Predictive Marker for Temozolomide Response in O6-methylguanine-DNA Methyltransferase Negative Glioblastoma Cells and Tumor Xenografts." Neuro Oncol 2016.